In the inflamed gut, such as in patients with IBD, Ly6Chi monocytes upregulate TLR2 and NOD and can differentiate into DC‐like populations with potent antigen‐presentation and cytokine production (IL‐6 and IL‐23) capability [83]. The gene discussed is IL23A; the disease is inflammatory bowel disease.